PIGM, one of the most highly overexpressed genes in the comparison between normal and malignant plasma cells, and contributing to the classifier distinguishing between both, was also one of the overexpressed genes in the myeloma group with the adverse cytogenetic markers. This evidence concerns the gene PIGM and plasma cell myeloma.